Literature DB >> 21316403

Current strategies for subunit and genetic viral veterinary vaccine development.

Alejandro Brun1, Juan Bárcena, Esther Blanco, Belén Borrego, Daniel Dory, José M Escribano, Ghislaine Le Gall-Reculé, Javier Ortego, Linda K Dixon.   

Abstract

Developing vaccines for livestock provides researchers with the opportunity to perform efficacy testing in the natural hosts. This enables the evaluation of different strategies, including definition of effective antigens or antigen combinations, and improvement in delivery systems for target antigens so that protective immune responses can be modulated or potentiated. An impressive amount of knowledge has been generated in recent years on vaccine strategies and consequently a wide variety of antigen delivery systems is now available for vaccine research. This paper reviews several antigen production and delivery strategies other than those based on the use of live viral vectors. Genetic and protein subunit vaccines as well as alternative production systems are considered in this review.
Copyright © 2011 Elsevier B.V. All rights reserved.

Mesh：

Substances：

Year:  2011        PMID： 21316403     DOI： 10.1016/j.virusres.2011.02.006

Source DB:  PubMed          Journal:  Virus Res        ISSN： 0168-1702            Impact factor:   3.303


  28 in total

1.  SplitCore Technology Allows Efficient Production of Virus-Like Particles Presenting a Receptor-Contacting Epitope of Human IgE.

Authors:  A Zh Baltabekova; Zh S Shagyrova; A S Kamzina; M Voykov; Ye Zhiyenbay; E M Ramanculov; A V Shustov
Journal:  Mol Biotechnol       Date:  2015-08       Impact factor: 2.695

2.  Delivery strategies for novel vaccine formulations.

Authors:  Maria Trovato; Shelly J Krebs; Nancy L Haigwood; Piergiuseppe De Berardinis
Journal:  World J Virol       Date:  2012-02-12

3.  Structural basis for the development of avian virus capsids that display influenza virus proteins and induce protective immunity.

Authors:  Elena Pascual; Carlos P Mata; Josué Gómez-Blanco; Noelia Moreno; Juan Bárcena; Esther Blanco; Ariel Rodríguez-Frandsen; Amelia Nieto; José L Carrascosa; José R Castón
Journal:  J Virol       Date:  2014-12-17       Impact factor: 5.103

4.  HSV-1 amplicon vectors launch the production of heterologous rotavirus-like particles and induce rotavirus-specific immune responses in mice.

Authors:  Andrea S Laimbacher; Laura E Esteban; Alejandro A Castello; Juan C Abdusetir Cerfoglio; Marcelo H Argüelles; Graciela Glikmann; Alejandra D'Antuono; Nora Mattion; Mabel Berois; Juan Arbiza; Monika Hilbe; Elisabeth M Schraner; Michael Seyffert; Christiane Dresch; Alberto L Epstein; Mathias Ackermann; Cornel Fraefel
Journal:  Mol Ther       Date:  2012-06-19       Impact factor: 11.454

5.  Immune responses in mice vaccinated with virus-like particles composed of the GP5 and M proteins of porcine reproductive and respiratory syndrome virus.

Authors:  Hae-Mi Nam; Kyung-Sil Chae; Young-Jo Song; Nak-Hyung Lee; Joong-Bok Lee; Seung-Yong Park; Chang-Seon Song; Kun-Ho Seo; Sang-Moo Kang; Min-Chul Kim; In-Soo Choi
Journal:  Arch Virol       Date:  2013-02-08       Impact factor: 2.574

Review 6.  An Overview of Veterinary Viral Diseases and Vaccine Technologies.

Authors:  Alejandro Brun
Journal:  Methods Mol Biol       Date:  2022

7.  Inclusion of a specific T cell epitope increases the protection conferred against foot-and-mouth disease virus in pigs by a linear peptide containing an immunodominant B cell site.

Authors:  Carolina Cubillos; Beatriz G de la Torre; Juan Bárcena; David Andreu; Francisco Sobrino; Esther Blanco
Journal:  Virol J       Date:  2012-03-14       Impact factor: 4.099

8.  Is it possible to ensure COVID19 vaccine supply by using plants?

Authors:  Anirban Bhar
Journal:  Nucleus (Calcutta)       Date:  2021-07-02

9.  Formulation and delivery of vaccines: Ongoing challenges for animal management.

Authors:  Sameer Sharma; Lyn A Hinds
Journal:  J Pharm Bioallied Sci       Date:  2012-10

10.  DNA prime/Adenovirus boost malaria vaccine encoding P. falciparum CSP and AMA1 induces sterile protection associated with cell-mediated immunity.

Authors:  Ilin Chuang; Martha Sedegah; Susan Cicatelli; Michele Spring; Mark Polhemus; Cindy Tamminga; Noelle Patterson; Melanie Guerrero; Jason W Bennett; Shannon McGrath; Harini Ganeshan; Maria Belmonte; Fouzia Farooq; Esteban Abot; Jo Glenna Banania; Jun Huang; Rhonda Newcomer; Lisa Rein; Dianne Litilit; Nancy O Richie; Chloe Wood; Jittawadee Murphy; Robert Sauerwein; Cornelus C Hermsen; Andrea J McCoy; Edwin Kamau; James Cummings; Jack Komisar; Awalludin Sutamihardja; Meng Shi; Judith E Epstein; Santina Maiolatesi; Donna Tosh; Keith Limbach; Evelina Angov; Elke Bergmann-Leitner; Joseph T Bruder; Denise L Doolan; C Richter King; Daniel Carucci; Sheetij Dutta; Lorraine Soisson; Carter Diggs; Michael R Hollingdale; Christian F Ockenhouse; Thomas L Richie
Journal:  PLoS One       Date:  2013-02-14       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.